News 
Market Data 
Discover
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$TNDM | #Tandem Bullish on Break Above $100
Alert set for break above $100
Indicators bullish .
$105 First target with confluence of
Fibonacci expansion and extension level.
Strong historical weekly resistance level also.
$116 second target to dead cat bounce Fibonacci .382 level.
PLEASE GIVE US A LIKE IF YOU FIND OUR CONTENT HELPFUL, THANK YOU.
$TNDM Tandem Diabetes On Breakout Watch
Alert set for break above $93.00,
Indicators bullish .
$100 first target as key psychological resistance .
$105 second target with confluence of
Fibonacci expansion and extension level.
Strong historical weekly resistance level also.
PLEASE GIVE US A LIKE IF YOU FIND OUR CONTENT HELPFUL, THANK YOU.
Tandem Diabetes Care Inc Has Huge growth potential
Jim Cramer spoke with Kim Blickenstaff, executive chairman at Tandem Diabetes Care ( TNDM ) , which posted strong earnings last week but quickly reversed, Blickenstaff blamed the sudden reversal in their shares on global uncertainty. He said Tandem has no business in China and is in "acceleration mode."
Currently, only 30% of Type 1 diabetes patients are using a pump, Blickenstaff said, leaving a lot of room for growth for Tandem. The market potential is even greater worldwide, especially in Europe as the condition continues to become a epidemic.
The chart remains bullish but maybe more confirmation required before placing a trade.
TNDM buy 62.73
normal chart
log chart
Exploding Back to 70.00's Next week, Go Full Blast Buying now or cry!!! 
$$$$$ BOOM
Tandem Diabetes Care Inc $TNDM Retreats, Watch This Trade Level
Tandem Diabetes Care Inc (NASDAQ:TNDM), is a leading manufacturer and developer of medical devices for people with insulin dependent diabetes using its micro-delivery technology. The stock has been pulling back since March 22, 2019 when it traded as high $74.77 a share. Since that recent pivot top, the stock has pulled back and is now trading at $60.33 a share. Traders and investors should note the gap fill window around the $50.00 level on a daily chart. This level should be solid support. There was sideways consolidation around the $50.00 area before the gap higher breakout move in late February 2019 making this a good support level when tested. At this time, the company is scheduled to report earnings on April 25, 2019.
Nick Santiago
InTheMoneyStocks
TNDM buy 43.62
normal chart
log chart
|
Followers
|
26
|
Posters
|
|
|
Posts (Today)
|
0
|
Posts (Total)
|
282
|
|
Created
|
11/26/13
|
Type
|
Free
|
| Moderators | |||
Tandem Diabetes Care, Inc. is a medical device company with an innovative, user-centric and integrated approach to the design, development and commercialization of products for people with diabetes who use insulin. The Company manufactures and sells a family of insulin pump products, which includes the t:slim X2™ Insulin Pump, the next-generation color touchscreen pump, the t:flex® Insulin Pump, the first pump designed for people with greater insulin requirements, and the t:slim G4™ Insulin Pump, the first CGM-enabled pump with touch-screen simplicity. Tandem is based in San Diego, California.
We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put Tandem Diabetes Care's financial performance into perspective
NOVEMBER 10th NEWS - HUGE 
